873 related articles for article (PubMed ID: 32228577)
1. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
[TBL] [Abstract][Full Text] [Related]
2. Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008-2011.
Moazzeni SS; Ghafelehbashi H; Hasheminia M; Parizadeh D; Ghanbarian A; Azizi F; Hadaegh F
BMC Public Health; 2020 Oct; 20(1):1510. PubMed ID: 33023566
[TBL] [Abstract][Full Text] [Related]
3. Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.
Kabootari M; Asgari S; Ghavam SM; Abdi H; Azizi F; Hadaegh F
J Transl Med; 2021 Jun; 19(1):277. PubMed ID: 34193200
[TBL] [Abstract][Full Text] [Related]
4. Three-year change in glycemic state and the future risk of incident hypertension among Iranian adults: Tehran Lipid and Glucose Study.
Moazzeni SS; Dehghani S; Hasheminia M; Hizomi Arani R; Azizi F; Hadaegh F
J Hum Hypertens; 2023 Oct; 37(10):944-949. PubMed ID: 36473941
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
[TBL] [Abstract][Full Text] [Related]
6. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
Janghorbani M; Amini M
Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
[TBL] [Abstract][Full Text] [Related]
8. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
[TBL] [Abstract][Full Text] [Related]
9. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
Chen Y; Zhang P; Wang J; Gong Q; An Y; Qian X; Zhang B; Li H; Gregg EW; Bennett PH; Li G
Diabetologia; 2021 Jun; 64(6):1279-1287. PubMed ID: 33608769
[TBL] [Abstract][Full Text] [Related]
10. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging.
Blake DR; Meigs JB; Muller DC; Najjar SS; Andres R; Nathan DM
Diabetes; 2004 Aug; 53(8):2095-100. PubMed ID: 15277391
[TBL] [Abstract][Full Text] [Related]
11. Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity.
Faeh D; William J; Yerly P; Paccaud F; Bovet P
Cardiovasc Diabetol; 2007 Oct; 6():32. PubMed ID: 17958881
[TBL] [Abstract][Full Text] [Related]
12. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
[TBL] [Abstract][Full Text] [Related]
13. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.
Festa A; D'Agostino R; Hanley AJ; Karter AJ; Saad MF; Haffner SM
Diabetes; 2004 Jun; 53(6):1549-55. PubMed ID: 15161760
[TBL] [Abstract][Full Text] [Related]
14. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
Tominaga M; Eguchi H; Manaka H; Igarashi K; Kato T; Sekikawa A
Diabetes Care; 1999 Jun; 22(6):920-4. PubMed ID: 10372242
[TBL] [Abstract][Full Text] [Related]
15. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.
Weyer C; Bogardus C; Pratley RE
Diabetes; 1999 Nov; 48(11):2197-203. PubMed ID: 10535454
[TBL] [Abstract][Full Text] [Related]
16. Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes.
Liu Y; Li J; Wu Y; Zhang H; Lv Q; Zhang Y; Zheng X; Tong N
Front Endocrinol (Lausanne); 2022; 13():835460. PubMed ID: 35250886
[TBL] [Abstract][Full Text] [Related]
17. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
Unwin N; Shaw J; Zimmet P; Alberti KG
Diabet Med; 2002 Sep; 19(9):708-23. PubMed ID: 12207806
[TBL] [Abstract][Full Text] [Related]
18. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
[TBL] [Abstract][Full Text] [Related]
19. Comparison of glucose tolerance categories in the Korean population according to World Health Organization and American Diabetes Association diagnostic criteria.
Park KS; Park YJ; Kim SW; Shin CS; Park DJ; Koh JJ; Kim SY; Kim NK; Lee HK
Korean J Intern Med; 2000 Jan; 15(1):37-41. PubMed ID: 10714090
[TBL] [Abstract][Full Text] [Related]
20. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
